10-Q: The Joint Corp. Reports Q1 2025 Results: Focus Shifts to Franchise Growth Amidst Refranchising Strategy

The Joint Corp. announces its Q1 2025 financial results, highlighting a strategic shift towards franchise-focused expansion and the ongoing refranchising of company-owned clinics.

Summary

• The Joint Corp. reported its Q1 2025 financial results, showing a net income of $801,430.
• The company is focusing on franchise-led growth and is in the process of refranchising its company-owned clinics.
• Revenues increased by 7.3% to $13.08 million, driven by royalty and franchise fee growth.
• Comparable sales for clinics open at least 13 months increased by 3.1%.
• System-wide sales grew by 5.0% to $132.6 million.
• The company sold nine franchise licenses in Q1 2025, with regional developers responsible for 56% of those sales.
• The company anticipates a volatile macroeconomic environment in 2025.
• The company expects to complete the sale of its corporate clinic portfolio within one year, estimating a fair value of $13.5 million as of March 31, 2025.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive. The company is showing revenue growth and is executing its strategic shift towards franchising. However, increased expenses and macroeconomic uncertainties temper the overall outlook.

Positives

• Revenue increased by 7.3% to $13.08 million.
• Comparable sales for clinics open at least 13 months increased by 3.1%.
• System-wide sales grew by 5.0% to $132.6 million.
• The company is actively refranchising its company-owned clinics, which is expected to generate value-creating capital allocation opportunities.
• The company has received significant interest in its refranchising efforts from existing franchisees, multi-unit operators, and private equity firms.

Negatives

• Loss from operations increased by $0.3 million to $(678,534).
• Selling and marketing expenses increased significantly due to digital marketing transformation efforts.
• The company anticipates a volatile macroeconomic environment in 2025, which could impact its business.

Risks

• The nationwide labor shortage has negatively impacted the ability to recruit chiropractors and other qualified personnel.
• Inflation leading to increased labor costs and interest rates may lead to reduced discretionary spending.
• The company may not be able to successfully implement its growth strategy if franchisees are unable to secure appropriate clinic locations.
• The chiropractic industry is highly competitive, which could prevent the company from increasing its market share.
• IT security systems may be breached, negatively affecting the ability to attract and retain patients.

Future Outlook

The company plans to continue its franchise-focused expansion and complete the refranchising of its company-owned clinics within one year. The company anticipates a volatile macroeconomic environment in 2025 and expects to use or redeploy its cash resources to support the business within the context of prevailing market conditions.

Management Comments

• The refined strategy will leverage our greatest strength our capacity to build a franchise to drive long-term growth for both our franchisees and The Joint as a public company.
• Our goal will be to generate significant processes that will provide us with value creating capital allocation opportunities.

Industry Context

The Joint Corp. operates in the chiropractic industry, which is highly competitive with many well-established independent competitors. The company's franchise model and focus on affordable, accessible chiropractic care differentiate it from traditional insurance-based practices.

Comparison to Industry Standards

• While specific competitor data isn't provided, the report highlights The Joint Corp.'s focus on a cash-based, non-insurance model, which contrasts with traditional chiropractic practices that rely on insurance reimbursements.
• The company's growth strategy emphasizes franchise expansion, similar to other franchise-based healthcare providers.
• Comparable sales growth of 3.1% indicates a healthy performance compared to broader retail and service industry benchmarks, but specific chiropractic industry benchmarks would provide a more precise comparison.

Legal Proceedings

• The Company entered into settlement agreements from litigation related to employment matters of $1.5 million that was outside the normal course of business.
• Litigation related to a medical injury claim between a patient and the Company filed on September 5, 2023, reached a settlement agreement on February 25, 2025.

Related Party Transactions

• Marshall Gramm, who is a family member of Mr. Jefferson Gramm, owns four franchise licenses.
• In October 2020, Mr. Gramm loaned approximately $370,000 to an unaffiliated franchisee that owns and operates one franchise clinic.

Stakeholder Impact

• Shareholders: The company's strategic shift towards franchising and potential capital allocation opportunities could impact shareholder value.
• Franchisees: The refranchising of company-owned clinics presents opportunities for existing and new franchisees to expand their operations.
• Employees: The refranchising plan may result in changes to employment at company-owned clinics.
• Patients: The company's focus on affordable, accessible chiropractic care aims to benefit patients seeking wellness solutions.

Next Steps

• Continue refranchising company-owned clinics.
• Leverage the regional developer program to accelerate franchise sales.
• Reinvest in the brand and related marketing.
• Continue investment in IT platforms.
• Evaluate potential merger or acquisition opportunities and/or a stock repurchase program.

Key Dates

Keywords

franchise, chiropractic, clinics, refranchising, sales, revenue, EBITDA, Joint Corp, JYNT